SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-003061
Filing Date
2015-08-13
Accepted
2015-08-13 16:30:59
Documents
1
Period of Report
2015-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11752
  Complete submission text file 0000899243-15-003061.txt   13144
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLOVIS ONCOLOGY, INC. 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Rolfe Lindsey (Reporting) CIK: 0001650504 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35347 | Film No.: 151051068